Compound ID | 483
Class: Quinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | DNA gyrase inhibitors; DNA topoisomerase inhibitors; active against atypical respiratory tract infection |
| Institute where first reported: | Procter and Gamble Pharmaceuticals, US |
| Year first mentioned: | 2000 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/273122357 |
| Citations: |
|